Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemophagocytic lymphohistiocytosis in HIV-related lymphomas: a multicentre retrospective cohort study.

Leukemia·2026
Same author

Integrase inhibitors and paclitaxel for Kaposi sarcoma: Clinical relevance of pharmacological interaction.

HIV medicine·2025
Same author

STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma.

BMC cancer·2025
Same author

Hepatocellular carcinoma in people living with HIV.

Journal of hepatology·2025
Same author

Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial.

BMC cancer·2025
Same author

Unilateral choroidal effusion secondary to carotid cavernous fistula.

BMJ case reports·2025

Related Experiment Video

Updated: Jun 27, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

Imaging in multicentric Castleman's disease.

Robert Barker1, Fahrad Kazmi, Mark Bower

  • 1Department of Oncology, Imperial College School of Medicine, London, UK.

Journal of HIV Therapy
|November 29, 2008
PubMed
Summary
This summary is machine-generated.

Multicentric Castleman disease (MCD) is a rare disorder often seen in HIV-1 patients. FDG PET-CT shows promise in monitoring MCD activity alongside other diagnostic tools.

More Related Videos

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

Related Experiment Videos

Last Updated: Jun 27, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

Area of Science:

  • Oncology
  • Infectious Diseases
  • Radiology

Background:

  • Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder.
  • It commonly presents with fever, anemia, and lymphadenopathy, particularly in individuals with HIV-1.
  • Current diagnostic methods, including CT scans, lack sufficient reliability, necessitating histological confirmation.

Purpose of the Study:

  • To evaluate newer imaging techniques for improved diagnostic accuracy in HIV-associated MCD.
  • To explore the utility of FDG PET-CT in monitoring disease activity.

Main Methods:

  • Review of preliminary findings on imaging techniques in patients with HIV-associated MCD.
  • Comparison of FDG PET-CT with established clinical, laboratory, and virological markers (HHV-8 DNA viral load).

Main Results:

  • CT scan findings are not definitive for MCD diagnosis.
  • Preliminary data suggest FDG PET-CT may aid in monitoring MCD disease activity.
  • FDG PET-CT complements traditional monitoring tools.

Conclusions:

  • Histological confirmation remains essential for MCD diagnosis.
  • FDG PET-CT shows potential as a valuable tool for monitoring disease activity in HIV-associated MCD.
  • Integrated monitoring using clinical, laboratory, virological, and imaging data improves disease management.